4731 - 4740 of 5857 Results
Title
Year
-
OPENTitle: Impaired perception of biological motion in Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 30Issue #: 6Start Page: 720End Page: 730Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1037/neu0000276Best OA location URL: https://doi.org/10.1037/neu0000276Citation Count: 45
- mGlu5positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome2016OPENTitle: mGlu5positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndromeJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 25Issue #: 10Start Page: 1990End Page: 2004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddw074Best OA location URL: https://academic.oup.com/hmg/article-pdf/25/10/1990/18527444/ddw074.pdfCitation Count: 54
- Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats2016OPENTitle: Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2016.01.020Best OA location URL: https://europepmc.org/articles/pmc4753102?pdf=renderCitation Count: 83
- 4-amino-7-chloroquinoline derivatives for treating Parkinson’s disease: implications for drug discovery2016OPENTitle: 4-amino-7-chloroquinoline derivatives for treating Parkinson’s disease: implications for drug discoveryJournal Name: Expert Opinion on Drug DiscoveryPublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 337End Page: 341Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1517/17460441.2016.1154529Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1517/17460441.2016.1154529?needAccess=trueCitation Count: 18
- Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase2016OPENTitle: Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid HydroxylaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 59Issue #: 6Start Page: 2579End Page: 2595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01780Best OA location URL: https://europepmc.org/articles/pmc4836378?pdf=renderCitation Count: 14
- Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia—A Meta-Regression Analysis2016OPENTitle: Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia—A Meta-Regression AnalysisJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2016.00046Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2016.00046/pdfCitation Count: 33
- Activation of the unfolded protein response promotes axonal regeneration after peripheral nerve injury2016OPENTitle: Activation of the unfolded protein response promotes axonal regeneration after peripheral nerve injuryJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep21709Best OA location URL: https://www.nature.com/articles/srep21709.pdfCitation Count: 89
-
OPENTitle: Central nervous system uptake of intranasal glutathione in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/npjparkd.2016.2Best OA location URL: https://www.nature.com/articles/npjparkd20162.pdfCitation Count: 50
- Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation2016OPENTitle: Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervationJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 4Start Page: 421End Page: 424Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1524-7Best OA location URL: https://europepmc.org/articles/pmc4805466?pdf=renderCitation Count: 27
- Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum2016OPENTitle: Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatumJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 19Issue #: 4Start Page: 578End Page: 586Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.4252Best OA location URL: https://europepmc.org/articles/pmc4853199?pdf=renderCitation Count: 156